Search research articles
Contact Us
Filters
Showing results (31-40 of 57) with videos related to
Page
of 6
Sort By:
Leukemia
|
July 8, 2023
Somatic TP53 single nucleotide variants, indels and copy number alterations in chronic myelomonocytic leukemia (CMML)
Mark Gurney, Abhishek A Mangaonkar, Terra Lasho, et al.
Haematologica
|
June 23, 2022
Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience
Ayalew Tefferi, Naseema Gangat, Mithun Shah, et al.
Blood Cancer Journal
|
September 22, 2023
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity
Talha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, et al.
British Journal of Haematology
|
March 18, 2020
Characteristics of patients with myelodysplastic syndrome with balanced translocations
Maansi Joshi, Patricia Greipp, Colleen Ball, et al.
British Journal of Haematology
|
March 5, 2025
Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome
Yael Kusne, Talha Badar, Terra Lasho, et al.
Leukemia Research
|
August 29, 2022
Comparison between GATA2 and DDX41-mutated myeloid neoplasms
Ahmad Nanaa, Rong He, David Viswanatha, et al.
American Journal of Clinical Pathology
|
June 6, 2018
Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow-Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation?
Hong Fang, Prashant Kapoor, Wilson I Gonsalves, et al.
Transplantation and Cellular Therapy
|
May 18, 2025
Comparison of Chimerism Kinetics and Associated Outcomes in Patients Receiving Post-Transplant Cyclophosphamide Versus Methotrexate based GVHD Prophylaxis Following Allogeneic Hematopoietic Cell Transplant
Anmol Baranwal, Christopher Graham, Khalil Hassan, et al.
Blood Advances
|
October 13, 2021
Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms
Hassan B Alkhateeb, Ahmad Nanaa, David Viswanatha, et al.
Blood Cancer Journal
|
April 9, 2023
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome
Aref Al-Kali, Ahmad Nanaa, David Viswanatha, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 57) with videos related to
Sort By:
Page
of 6
Leukemia
|
July 8, 2023
Somatic TP53 single nucleotide variants, indels and copy number alterations in chronic myelomonocytic leukemia (CMML)
Mark Gurney, Abhishek A Mangaonkar, Terra Lasho, et al.
Haematologica
|
June 23, 2022
Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience
Ayalew Tefferi, Naseema Gangat, Mithun Shah, et al.
Blood Cancer Journal
|
September 22, 2023
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity
Talha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, et al.
British Journal of Haematology
|
March 18, 2020
Characteristics of patients with myelodysplastic syndrome with balanced translocations
Maansi Joshi, Patricia Greipp, Colleen Ball, et al.
British Journal of Haematology
|
March 5, 2025
Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome
Yael Kusne, Talha Badar, Terra Lasho, et al.
Leukemia Research
|
August 29, 2022
Comparison between GATA2 and DDX41-mutated myeloid neoplasms
Ahmad Nanaa, Rong He, David Viswanatha, et al.
American Journal of Clinical Pathology
|
June 6, 2018
Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow-Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation?
Hong Fang, Prashant Kapoor, Wilson I Gonsalves, et al.
Transplantation and Cellular Therapy
|
May 18, 2025
Comparison of Chimerism Kinetics and Associated Outcomes in Patients Receiving Post-Transplant Cyclophosphamide Versus Methotrexate based GVHD Prophylaxis Following Allogeneic Hematopoietic Cell Transplant
Anmol Baranwal, Christopher Graham, Khalil Hassan, et al.
Blood Advances
|
October 13, 2021
Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms
Hassan B Alkhateeb, Ahmad Nanaa, David Viswanatha, et al.
Blood Cancer Journal
|
April 9, 2023
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome
Aref Al-Kali, Ahmad Nanaa, David Viswanatha, et al.
Page
of 6